274 related articles for article (PubMed ID: 8946935)
1. Drug resistance mechanisms in chronic lymphocytic leukemia.
Ribrag V; Massade L; Faussat AM; Dreyfus F; Bayle C; Gouyette A; Marie JP
Leukemia; 1996 Dec; 10(12):1944-9. PubMed ID: 8946935
[TBL] [Abstract][Full Text] [Related]
2. Glutathione system, topoisomerase II level and multidrug resistance phenotype in acute myelogenous leukemia before treatment and at relapse.
Massaad-Massade L; Ribrag V; Marie JP; Faussat AM; Bayle C; Dreyfus F; Gouyette A
Anticancer Res; 1997; 17(6D):4647-51. PubMed ID: 9494583
[TBL] [Abstract][Full Text] [Related]
3. Characterization of glutathione S-transferase expression in lymphocytes from chronic lymphocytic leukemia patients.
Schisselbauer JC; Silber R; Papadopoulos E; Abrams K; LaCreta FP; Tew KD
Cancer Res; 1990 Jun; 50(12):3562-8. PubMed ID: 2340505
[TBL] [Abstract][Full Text] [Related]
4. Glutathione-S-transferases pi, alpha, mu and mdr1 mRNA expression in normal lymphocytes and chronic lymphocytic leukemia.
Marie JP; Simonin G; Legrand O; Delmer A; Faussat AM; Lewis AD; Sikic BI; Zittoun R
Leukemia; 1995 Oct; 9(10):1742-7. PubMed ID: 7564519
[TBL] [Abstract][Full Text] [Related]
5. Alkylator resistance in human B lymphoid cell lines: (2). Increased levels of topoisomerase II expression and function in a melphalan-resistant B-CLL cell line.
Pu QQ; Bezwoda WR
Anticancer Res; 2000; 20(4):2569-78. PubMed ID: 10953328
[TBL] [Abstract][Full Text] [Related]
6. Glutathione-S-transferase activity and multidrug resistance phenotype in chronic lymphocytic leukemia: do they have any clinical relevance?
Di Simone D; Testi R; Caracciolo F; Capochiani E; Ambrogi F; Grassi B; Petrini M
Haematologica; 1995; 80(2):103-7. PubMed ID: 7543067
[TBL] [Abstract][Full Text] [Related]
7. Expression of multidrug-resistance-related proteins P-glycoprotein, glutathione-S-transferases, topoisomerase-II and lung resistance protein in primary gastric cardiac adenocarcinoma.
Shi H; Lu D; Shu Y; Shi W; Lu S; Wang K
Cancer Invest; 2008 May; 26(4):344-51. PubMed ID: 18443954
[TBL] [Abstract][Full Text] [Related]
8. C(H)OP refractory chronic lymphocytic leukemia patients in whom salvage chemotherapy chosen by evaluating multiple chemotherapeutic drug-resistant factors was remarkably effective.
Matsunaga T; Kogawa K; Fujimi A; Takizawa K; Takahira N; Takemoto N; Tanaka I; Akiyama T; Sato T; Takayama T; Terui T; Sakamaki S; Niitsu Y
Int J Clin Oncol; 2003 Oct; 8(5):326-31. PubMed ID: 14586760
[TBL] [Abstract][Full Text] [Related]
9. High dose chlorambucil versus Binet's modified cyclophosphamide, doxorubicin, vincristine, and prednisone regimen in the treatment of patients with advanced B-cell chronic lymphocytic leukemia. Results of an international multicenter randomized trial. International Society for Chemo-Immunotherapy, Vienna.
Jaksic B; Brugiatelli M; Krc I; Losonczi H; Holowiecki J; Planinc-Peraica A; Kusec R; Morabito F; Iacopino P; Lutz D
Cancer; 1997 Jun; 79(11):2107-14. PubMed ID: 9179056
[TBL] [Abstract][Full Text] [Related]
10. DNA repair and cellular resistance to alkylating agents in chronic lymphocytic leukemia.
Müller MR; Buschfort C; Thomale J; Lensing C; Rajewsky MF; Seeber S
Clin Cancer Res; 1997 Nov; 3(11):2055-61. PubMed ID: 9815597
[TBL] [Abstract][Full Text] [Related]
11. Expression of multidrug resistance-related proteins p-glycoprotein, glutathione-s-transferases, topoisomerase-II and lung resistance protein in primary gastric cardiac adenocarcinoma.
Shi H; Lu D; Shu Y; Shi W; Lu S; Wang K
Hepatogastroenterology; 2008; 55(86-87):1530-6. PubMed ID: 19102336
[TBL] [Abstract][Full Text] [Related]
12. Expression of genes of potential importance in the response to chemotherapy and DNA repair in patients with ovarian cancer.
Codegoni AM; Broggini M; Pitelli MR; Pantarotto M; Torri V; Mangioni C; D'Incalci M
Gynecol Oncol; 1997 Apr; 65(1):130-7. PubMed ID: 9103402
[TBL] [Abstract][Full Text] [Related]
13. Response to fludarabine in B-cell chronic lymphocytic leukemia patients previously treated with chlorambucil as up-front therapy and a CHOP-like regimen as second line therapy.
Liso V; Molica S; Capalbo S; Pogliani E; Battista C; Broccia G; Montillo M; Cuneo A; Leoni P; Specchia G; Castoldi G
Haematologica; 2001 Nov; 86(11):1165-71. PubMed ID: 11694402
[TBL] [Abstract][Full Text] [Related]
14. Expression of P-gp, MRP, LRP, GST-π and TopoIIα and intrinsic resistance in human lung cancer cell lines.
Wang J; Zhang J; Zhang L; Zhao L; Fan S; Yang Z; Gao F; Kong Y; Xiao GG; Wang Q
Oncol Rep; 2011 Nov; 26(5):1081-9. PubMed ID: 21805041
[TBL] [Abstract][Full Text] [Related]
15. Five putative drug resistance parameters (MDR1/P-glycoprotein, MDR-associated protein, glutathione-S-transferase, bcl-2 and topoisomerase IIalpha) in 57 newly diagnosed acute myeloid leukaemias. Swiss Group for Clinical Cancer Research (SAKK).
Lohri A; van Hille B; Bacchi M; Fopp M; Joncourt F; Reuter J; Cerny T; Fey MF; Herrmann R
Eur J Haematol; 1997 Oct; 59(4):206-15. PubMed ID: 9338618
[TBL] [Abstract][Full Text] [Related]
16. In vitro chemosensitivity of chronic lymphocytic leukemia B-cells to multidrug regimen (CEOP) compounds using the MTT colorimetric assay.
Morabito F; Messina G; Oliva B; Ramirez F; Callea V; Brugiatelli M; Nobile F
Haematologica; 1993; 78(4):213-8. PubMed ID: 8294052
[TBL] [Abstract][Full Text] [Related]
17. Chlorambucil in chronic lymphocytic leukemia: mechanism of action.
Begleiter A; Mowat M; Israels LG; Johnston JB
Leuk Lymphoma; 1996 Oct; 23(3-4):187-201. PubMed ID: 9031099
[TBL] [Abstract][Full Text] [Related]
18. Flow cytometric analysis of glutathione-S-transferase-pi in acute leukemia.
Tiirikainen MI; Elonen E; Syrjälä MT; Jansson SE; Krusius T
Leukemia; 1994 Jun; 8(6):978-84. PubMed ID: 7516031
[TBL] [Abstract][Full Text] [Related]
19. Alkylator resistance in human B lymphoid cell lines: (1). Melphalan accumulation, cytotoxicity, interstrand-DNA-crosslinks, cell cycle analysis, and glutathione content in the melphalan-sensitive B-lymphocytic cell line (WIL2) and in the melphalan-resistant B-CLL cell line (WSU-CLL).
Pu Q; Bianchi P; Bezwoda WR
Anticancer Res; 2000; 20(4):2561-8. PubMed ID: 10953327
[TBL] [Abstract][Full Text] [Related]
20. Comparison of fludarabine, cyclophosphamide/doxorubicin/prednisone, and cyclophosphamide/doxorubicin/vincristine/prednisone in advanced forms of chronic lymphocytic leukemia: preliminary results of a controlled clinical trial. The French Cooperative Group on Chronic Lymphocytic Leukemia.
Semin Oncol; 1993 Oct; 20(5 Suppl 7):21-3. PubMed ID: 8235691
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
